ライフサイエンスコーパス: biopsy sample

1 resence of the bacterium without obtaining a biopsy sample.

2 ased on a histopathological examination of a biopsy sample.

3 gorithm in less-invasive transbronchial lung biopsy samples.

4 mRNA expression in chronic HCV patient liver biopsy samples.

5 epatitis (NASH) mouse models and human liver biopsy samples.

6 tivity in NAFLD mouse models and human liver biopsy samples.

7 MCs was isolated from porcine endomyocardial biopsy samples.

8 2, CYSLTR1 and CYSLTR2 were expressed in all biopsy samples.

9 s in lipid composition in nine breast cancer biopsy samples.

10 xpression level was also measured from liver biopsy samples.

11 results of histopathologic analysis of skin biopsy samples.

12 Histologic analyses were performed on biopsy samples.

13 s of rejection in most isolated endarteritis biopsy samples.

14 nd accurate variant detection from low-input biopsy samples.

15 us normal areas of lung in IPF surgical lung biopsy samples.

16 cific antibodies [DSAs]) with 281 indication biopsy samples.

17 t rejection or pretransplant "normal kidney" biopsy samples.

18 interstitial lung diseases in surgical lung biopsy samples.

19 system was used to image ICG fluorescence in biopsy samples.

20 e or crossmatch-positive or had C4d-positive biopsy samples.

21 erived xenografts were established from core biopsy samples.

22 ad both high-resolution CT and surgical lung biopsy samples.

23 dependently assessed anonymised CT scans and biopsy samples.

24 Rbm20 that is consistent with human cardiac biopsy samples.

25 onses in a subset of patients with available biopsy samples.

26 m for PDX development from both surgical and biopsy samples.

27 low-cost and applicable to standard clinical biopsy samples.

28 showed no evidence of viral particles in the biopsy samples.

29 eal-time reverse transcriptase-PCR of tissue biopsy samples.

30 ed on immunohistochemistry from image-guided biopsy samples.

31 validate the system along with human colonic biopsy samples.

32 prominent complement C3 deposition in kidney biopsy samples.

33 tment and two did not provide post-treatment biopsy samples.

34 itro and in mucus from mouse and human colon biopsy samples.

35 lung transplant cohort undergoing consistent biopsy sampling.

36 vated cell sorting analysis was performed on biopsy samples 1 hour after therapy.

37 [0.7-2.0] vs 1.8 [1.6-2.3], p=0.002; and in biopsy samples 1.3 [0.7-2.3] vs 3.9% [1.3-5.3%], p=0.02)

38 mples, 71.7% (81 of 113) for nasal turbinate biopsy samples, 19.5% (22 of 113) for blood samples, wit

39 al swab samples, 53.8% (56 of 104) for nasal biopsy samples, 6.7% (7 of 104) for blood samples, and 1

40 by immunofluorescence microscopy in 9 of 10 biopsy samples (90%) at 3 months, in 8 of 12 samples (66

41 composition of cancer subpopulations in the biopsy sample, a fundamental step to determine clonal ex

42 On pathologic examination of the biopsy samples, all were positive for malignancy.

43 tio per cell (an average of 47,000 cells per biopsy sample analyzed).

44 molecular markers of endocrine tissue in BM biopsy samples analyzed during follow-up.

45 ger patient population and analyzed duodenal biopsy samples and fluid from patients to investigate me

46 Duodenal biopsy samples and fluid were collected 2 weeks before a

47 ting and subsequently obtained surgical lung biopsy samples and from lung explants.

48 ticle we show high production of IL-1beta in biopsy samples and Leishmania antigen-stimulated periphe

49 In gut biopsy samples and lymph-node tissue, cell-copy number a

50 left ventricle dilated cardiomyopathy (DCM) biopsy samples and mouse models of DCM through BioID pro

51 ing in vitro organ culture (IVOC) of colonic biopsy samples and polarized T84 colon carcinoma cells.

52 d be useful in identifying tumour regions in biopsy samples and tissue microarray images.

53 their assigned treatment, provided evaluable biopsy samples, and did not have major protocol deviatio

54 s, primary cell cultures, ex vivo specimens, biopsy samples, and fixed post-mortem tissue.

55 henotype such cells from human kidney tissue biopsy samples, and immunofluorescence microscopy to loc

56 tions, paired surgical resection/core needle biopsy samples, and paired samples from 69 patients of a

57 evels of tenascin-C are elevated in SSc skin biopsy samples, and serum and SSc fibroblasts, and in fi

58 aggregates in the cortical area of LD brain biopsy samples, and there is also a dramatic loss of par

59 BKVN and normal transplant kidney biopsy samples, and whole blood samples of patients with

60 d histological analyses of an endomyocardial biopsy sample are indicated when inflammation or infecti

61 reath, urine, blood, interstitial fluid, and biopsy samples are summarized.

62 Because biopsy samples are too insensitive to reliably detect BO

63 suitable treatment for a specific patient if biopsy samples are used.

64 Tissue biopsy samples are widely used to characterize tumours b

65 o detect and grade cancer in prostate needle biopsy samples at a ranking comparable to that of intern

66 We obtained six re-biopsy samples at acquired resistance from the intrinsic

67 detectable for all genes in malignant needle biopsy samples (AUC: 0.80 to 0.98), confirming previous

68 that complements the assessment of a kidney biopsy sample by a pathologist.

69 first time that EHEC colonizes human colonic biopsy samples by forming typical attaching and effacing

70 of specific gene transcripts in pathological biopsy samples by rapid in-situ RNA technology and singl

71 Although skin biopsy samples can be used to directly measure topical d

72 he immune microenvironment in primary tissue biopsy samples can be used to stratify patients accordin

73 Kidney biopsy samples can show definitive evidence of CKD, thro

74 A from leukocytes and fixed esophageal tumor biopsy samples collected during esophagogastroduodenosco

75 molecular markers of endocrine tissue in BM biopsy samples collected during follow-up.

76 s cytometry to study immune cells from nasal biopsy samples collected following experimental human pn

77 We analyzed mucosal biopsy samples collected from 101 patients with IBS and

78 ions: Autologous keratinocytes isolated from biopsy samples collected from 4 patients with RDEB were

79 blood, lymph node (LN), and colorectal (RB) biopsy samples compared to 15 noncontroller (NC) RMs.

80 nophilic esophagitis or eosinophil counts in biopsy samples compared with placebo.

81 icroRNA sequencing in 74 frozen osteosarcoma biopsy samples, constituting the largest single center t

82 Nineteen of 38 core biopsy samples contained cancer.

83 aled a substantial Treg population in muscle biopsy samples containing AAT-expressing myofibers.

84 Hair follicle biopsy samples demonstrated evidence of Wee1 inhibition

85 or tissue microarrays, cDNA arrays and tumor biopsy samples demonstrated V2R expression and activity

86 been used to identify features in human skin biopsy samples diagnosed for basal cell carcinoma (BCC)

87 For ex vivo biopsy samples, diagnostic yield was 100% using 25 G nee

88 atients in silico to evaluate the effects of biopsy sampling, diagnostic sensitivity, and treatment o

89 Histopathologic examination of biopsy samples disclosed moderate intraparenchymal fibro

90 ot predict sorafenib concentrations in tumor biopsy samples during therapy.

91 d protease activity in human prostate cancer biopsy samples, enabling disease classification.

92 Of 100 molecular prognostic biopsy samples evaluated, 65 were obtained using 27 G ne

93 romycin can be predicted without obtaining a biopsy sample, facilitating the choice of the right ther

94 racted from PBMCs, sorted B cells, and nasal biopsy samples for heavy chain variable gene repertoire

95 pplications for clinically diagnosing liquid biopsy samples for patients with lung cancer.

96 -PCR, immunohistochemical staining of kidney biopsy samples for SARS-CoV-2 was negative in all ten pa

97 The MITS included needle core-biopsy sampling for histopathology of brain, lung, and l

98 Shallow whole-genome sequencing of 777 biopsies, sampled from 88 patients in Barrett's esophagu

99 of gadolinium in the human organism, a skin biopsy sample from a suspected NSF patient was investiga

100 Chondrocytes (isolated from a 6 mm cartilage biopsy sample from the nasal septum harvested under loca

101 t, direct immunofluorescent examination of a biopsy sample from the patient's perilesional skin demon

102 a marker of dendritic cells in 105 allograft biopsy samples from 105 kidney transplant recipients.

103 Studying 213 archival biopsy samples from 17 patients, we used somatic variant

104 of the skin showed necrotizing vasculitis in biopsy samples from 40 of 50 children.

105 We analyzed colon biopsy samples from 40 patients with IBS (IBS biopsies)

106 nterstitial pneumonia in transbronchial lung biopsy samples from 49 patients with 88% specificity (95

107 Eighteen biopsy samples from 6 patients were retrieved from our h

108 We obtained liver biopsy samples from 69 patients with chronic HCV infecti

109 We obtained fixed liver biopsy samples from 71 consecutive patients diagnosed wi

110 Lesional skin biopsy samples from 81 patients with moderate-to-severe

111 (anti-IL-13 mAb) modulates EMT biomarkers in biopsy samples from adults with active EoE in a substudy

112 ound in areas surrounding amyloid plaques in biopsy samples from Alzheimer's disease (AD) brains.

113 eplicon-harboring cells, as well as in liver biopsy samples from chronically HCV-infected patients.

114 Levels of occludin were lower in duodenal biopsy samples from CLE(+) patients vs controls (P = .02

115 ocytes were significantly higher in duodenal biopsy samples from CLE(+) vs CLE(-) patients or control

116 btained from 49 patients and 55 in vivo lung biopsy samples from computed tomographic [CT]-guided lun

117 analyzed the expression of PDGF-BB in muscle biopsy samples from controls and patients with DMD.

118 erating and necrotic muscle fibers in muscle biopsy samples from DMD patients expressed PDGF-BB.

119 m the ileum, splenic flexure, and rectum (18 biopsy samples from each patient).

120 rs and adipophilin in at least 1 of multiple biopsy samples from each patient.

121 lium of the esophagus, as well as in control biopsy samples from esophageal squamous epithelium of pa

122 of four volunteers, and by RT-PCR in muscle biopsy samples from four volunteers.

123 tokine in a mouse model of BA and in hepatic biopsy samples from infants with BA.

124 Ex vivo molecular MR imaging of liver biopsy samples from NASH and control patients confirmed

125 We analyzed biopsy samples from paired baseline and relapsing lesion

126 ients with gastric adenocarcinoma as well as biopsy samples from patients infected with H. pylori sho

127 cells that were essentially undetectable in biopsy samples from patients on a gluten-free diet but e

128 levels of IGF-1R and IRS-1 are increased in biopsy samples from patients progressing on crizotinib m

129 Moreover, immunohistochemical analyses of biopsy samples from patients revealed localization of TH

130 lls dying of this pathway and in human liver biopsy samples from patients suffering from drug-induced

131 Skin biopsy samples from patients with AD show greater EMSY s

132 y, we performed microarray analyses of renal biopsy samples from patients with ANCA-associated cresce

133 significantly decreased in small intestinal biopsy samples from patients with celiac disease, which

134 Using microarray analysis of bronchial biopsy samples from patients with COPD and controls, we

135 We obtained blood and colon biopsy samples from patients with Crohn's disease or ulc

136 We obtained muscle biopsy samples from patients with diabetes who were unde

137 and protein expression of ANO1 in esophageal biopsy samples from patients with EoE and in mice with E

138 rved increased ANO1 expression in esophageal biopsy samples from patients with EoE and in mice with E

139 ased expression of Filamin-B in podocytes in biopsy samples from patients with FSGS, in single glomer

140 dies and glomerular target antigens in renal biopsy samples from patients with LN and determine wheth

141 able macrophage phenotype composition within biopsy samples from patients with locally invasive recta

142 The application of these methods to kidney biopsy samples from patients with lupus nephritis has be

143 In kidney biopsy samples from patients with nephropathic cystinosi

144 he current study investigated endomyocardial biopsy samples from patients with TCM and compared them

145 sease activity was evaluated in 2630 colonic biopsy samples from patients with UC treated in the UNIF

146 We evaluated renal biopsy samples from patients with various forms of cresc

147 We collected surgical lung biopsy samples from patients with various interstitial l

148 d a systematic analysis of urine and bladder biopsy samples from postmenopausal women undergoing cyst

149 opsy specimens from 74 patients (177 ex vivo biopsy samples from surgically resected masses were obta

150 The most common finding in our kidney biopsy samples from ten hospitalized patients with AKI a

151 lonogenic cells from 1-mm-diamter endoscopic biopsy samples from the human gastrointestinal tract.

152 We also collected 160 large-bowel biopsy samples from the patients at study entry, at comp

153 crine prostate cancer (CRPC-NE); analysis of biopsy samples from the same individuals over time point

154 on and microRNA expression profiles in renal biopsy samples from tolerance-induced FCRx recipients, p

155 gulated in vitiligo cell line PIG3V and skin biopsy samples from vitiligo patients, whereas its predi

156 eviates the need for inefficient imaging and biopsy sampling from potential metastatic target tissues

157 ring the inclusion period, we identified 552 biopsy samples (from 385 patients) with transplant glome

158 Thanks to clinically accessible biopsy samples, high-quality molecular data for psoriasi

159 and gene expression profiling from the same biopsy sample) identified the induction of regulators wi

160 We collected 248 liquid biopsy samples including plasma, cell pellet (UCP) and s

161 We analyzed 46 fresh lymph node biopsy samples, including FL (n = 20), diffuse large B-c

162 Although NNMT expression in human fat biopsy samples increased during WR, corresponding plasma

163 Analysis of biopsy samples indicated that several anti-inflammatory

164 rom 3.02 to 4.58 mg/kg was determined in the biopsy sample, indicating a considerable deposition of g

165 in the evolution of the disease process the biopsy sample is taken.

166 However, genotyping of tumour biopsy samples is not feasible for all patients and, the

167 were assessed at Weeks 0 and 12, along with biopsy sampling (m.

168 ations during therapy in corresponding tumor biopsy samples measured with liquid chromatography tande

169 and may evade detection by random esophageal biopsy sampling methods.

170 pattern on high resolution CT, surgical lung biopsy sampling might not be necessary to reach a diagno

171 .21-1.87], P < 0.001), and those receiving a biopsy sampling more often had multifocal lesions (HR =

172 trogen (delta(15) N) isotope values from SRW biopsy samples (n = 122) collected during these two dist

173 Blubber biopsy samples (n = 185) of female humpback whales were

174 Liver biopsy samples, NIT results, and PROs (Short Form-36, Ch

175 Colonization of neither biopsy samples nor T84 cells was significantly affected

176 se intragraft injury processes was better in biopsy samples obtained >3 months after transplant (AUC

177 ily members in detail, along with autopsy or biopsy samples obtained from 5 family members.

178 We evaluated the EDP signature in biopsy samples obtained from adult and pediatric patient

179 Liver biopsy samples obtained from HBV-chronic individuals wer

180 lasma proteins and 2619 proteins in duodenal biopsy samples obtained from these children.

181 Biopsy samples obtained from vastus lateralis muscles of

182 Overall mean number of core needle biopsy samples obtained was 7.9 samples.

183 us for cancer in each patient, with adequate biopsy samples obtained with each biopsy attempt.

184 n-alcoholic steatohepatitis and cirrhosis in biopsied samples of human liver tissue.

185 a mouthwash, and discriminate between fresh biopsied samples of the oral tumour and the surgical res

186 2 transcript was also observed in the muscle biopsy sample of the patient with p.A35T mutation.

187 l IFNalpha treatment or between pretreatment biopsy samples of 11 IFNalpha responders and 11 non-resp

188 ption-polymerase chain reaction (qRT-PCR) in biopsy samples of 19 patients with esophageal squamous c

189 Glomeruli were microdissected from biopsy samples of 20 patients with LN and characterized

190 ted antigens from laser-microdissected renal biopsy samples of 20 patients with LN.

191 ar quantification of steroids in core needle biopsy samples of breast tissue to inform dosage and tim

192 e global transcriptional alterations in skin biopsy samples of EM lesions from untreated adult patien

193 al fibroblasts were isolated from esophageal biopsy samples of healthy donors or patients with active

194 roducts, characteristics not seen in control biopsy samples of healthy muscle and immune-mediated myo

195 Biopsy samples of inflamed colonic mucosa from patients

196 ion of the cell populations present in small biopsy samples of kidney tissue.

197 established cell culture models derived from biopsy samples of lung cancer patients whose disease had

198 We evaluated biopsy samples of native and allograft kidneys from pati

199 tients without GC (AG/IM GC-) and in control biopsy samples of non-transformed gastric mucosa (Contro

200 ell laser capture microdissection from liver biopsy samples of patients chronically infected with HCV

201 testinal defects, and colonoids derived from biopsy samples of patients with and without mutations in

202 In ileal biopsy samples of patients with CD, there was an inverse

203 ly, abnormal Notch3 staining was observed in biopsy samples of patients with crescentic GN.

204 We conducted a retrospective study using biopsy samples of psoriasis, AD, and erythroderma belong

205 ring flap refinement after 6 months, we took biopsy samples of repair tissues and histologically anal

206 ning showed decreased expression of PADI3 in biopsy samples of scalp skin obtained from patients with

207 At operation 2 cm(3) biopsy samples of subcutaneous and visceral adipose tiss

208 ion (one in the AMG 714 group), insufficient biopsy samples (one in the AMG 714 group), and atypical

209 variant detection is appropriate for liquid biopsy samples or other limited clinical biospecimens.

210 compared with histopathology of core needle biopsy samples or with ultrasound follow-up data of the

211 f single-cell technologies to clinical renal biopsy samples, or even cells within urine, will improve

212 mmediately after RF ablation (mean number of biopsy samples per ablation zone, 1.9) and was evaluated

213 detected when increasing the number of core biopsy samples per index lesion from one to three and fr

214 The inclusion criteria was the presence of biopsy sample proven localised amyloidosis classified as

215 We found that individual clusters on biopsy samples range in size from 4-50 infected cells.

216 Although the biopsy samples represented a mixed cell population, the

217 l diversity that is captured in single tumor biopsy samples represents only a small proportion of the

218 annexin AI were detected in 11 and 10 of the biopsy samples, respectively, and predominated over othe

219 nd C1q were detected in 50%, 55%, and 70% of biopsy samples, respectively.

220 hylated region methylation status in 1-month biopsy samples revealed a nonsignificant trend for highe

221 Immunohistochemistry of endomyocardial biopsy samples revealed altered expression of the trunca

222 we analyzed the gene expression of human OS biopsy samples, revealing that miR-449a and miR-424 are

223 re, similar analyses in chronic pancreatitis biopsy samples showed the presence of acinar-REG(+) cell

224 Human liver biopsy samples showed the presence of the HCV-specific f

225 of single-cell RNA sequencing data from six biopsy samples showed two major fibroblast populations,

226 All biopsy samples showed varying degrees of acute tubular n

227 value of dendritic cell density in allograft biopsy samples, suggest a new role for these cells in sh

228 Gastric biopsy samples taken at baseline and 3, 6, 12, 16, and 2

229 ion quantification was performed on duodenal biopsy samples taken at the end of each phase of supplem

230 les were compared between seven paired liver biopsy samples taken before and 6 months after successfu

231 ced metabolic perturbation assayed in muscle biopsy samples taken from locomotor muscle.

232 tients with HGSOC were imaged at 3 T and had biopsy samples taken prior to any treatment.

233 unaffected relatives were recruited and skin biopsy samples taken.

234 lication of PARPi-FL on freshly excised cone biopsy samples, the nuclei of tumor cells emitted a spec

235 ch group had a pneumothorax from a CT-guided biopsy sample; the patient from the CDS group needed int

236 infiltration and fibrosis in endomyocardial biopsy samples to assess transplant rejection.

237 tion assay of tissue from routine diagnostic biopsy samples to determine the cell-of-origin subtype o

238 nalysis of blood, lymph node, and colorectal biopsy samples to further understand the characteristics

239 d in combination with histologic analysis of biopsy samples to stratify patients for treatment.

240 Biopsy samples underwent digital image analysis and asse

241 Eleven human liver biopsy samples underwent MPO-Gd-enhanced MR imaging ex v

242 We now report a retrospective study of human biopsy samples using biomarker ratio imaging microscopy

243 ogy method and fat content was quantified in biopsy samples using stereologic point counts (SPCs).

244 IgH V regions used by the BCRs of ABC DLBCL biopsy samples varied in their ability to sustain surviv

245 A 1-clock hour limbal biopsy sample was obtained from the unaffected eye.

246 rrently, his previously obtained pelvic mass biopsy sample was sent for panel-based genomic profiling

247 usion PD-L1 expression in pretreatment tumor biopsy samples was correlated with response rate, PFS, a

248 affects repair, microarray analysis of wound biopsy samples was performed on days 3, 7, 10, and 14 af

249 Expression of selected genes in the same biopsy samples was tested with qRT-PCR.

250 Needle biopsies samples were taken from the vastus lateralis mu

251 IL28A, IL28RA, and other related cytokines; biopsy samples were also analyzed by immunofluorescence

252 es of 28 TGP and 11 normal transplant kidney biopsy samples were analyzed by Affymetrix HuGene 1.0 ST

253 Liver biopsy samples were analyzed by histology and scored cen

254 Biopsy samples were analyzed for mutations and protein e

255 Liver biopsy samples were available for 1201 patients (97.2% o

256 during early experimental acute AD lesions, biopsy samples were collected 6, 24, and 48 hours after

257 subjects); 232 fecal samples and 59 mucosal biopsy samples were collected and analyzed by 16S riboso

258 Biopsy samples were collected and H pylori were isolated

259 Blood and muscle biopsy samples were collected at rest and after exercise

260 Two endoscopic biopsy samples were collected at weeks 0, 8, and 44 from

261 Blood and muscle biopsy samples were collected before and after the inges

262 Blood and liver biopsy samples were collected before treatment and at tr

263 Abdominal subcutaneous adipose tissue biopsy samples were collected for microarray analysis.

264 led, time course SLIT study, PBMCs and nasal biopsy samples were collected from 40 adults with season

265 Three to five transbronchial lung biopsy samples were collected from all patients specific

266 ; interquartile range, 53-65 months); random biopsy samples were collected from neosquamous epitheliu

267 Blood and muscle biopsy samples were collected over 360 min of postexerci

268 Repeated blood and muscle biopsy samples were collected to assess whole-body leuci

269 d and microscopic sections of lacrimal gland biopsy samples were critically re-evaluated.

270 Intraocular biopsy samples were cultured by standard methods.

271 Bone or soft-tissue biopsy samples were evaluated.

272 Biopsy samples were histologically graded as CIN2+ or <C

273 Biopsy samples were obtained at baseline and week 12 for

274 Small bowel biopsy samples were obtained for histological assessment

275 Fecal and intestinal biopsy samples were obtained from 107 healthy individual

276 Tendon tissue biopsy samples were obtained from 20 patients with ruptu

277 der-collected cervical samples, and cervical biopsy samples were obtained from all enrolled women.

278 Biopsy samples were obtained from subcutaneous abdominal

279 ajority of dendritic cells in late allograft biopsy samples were of recipient origin.

280 Esophageal biopsy samples were quantified for levels of eosinophils

281 Throughout the study, 1,007 biopsy samples were reported as malignant tumors (719 ga

282 of cells isolated from the placenta and all biopsy samples were stained positive for Cytokeratin 7,

283 The resected tumour specimen and individual biopsy samples were studied to assess the true tumour ma

284 Biopsy samples were taken before and after allergen chal

285 Biopsy samples were taken from 29 patients with locally

286 Baseline and week 16 esophageal biopsy samples were taken from 69 patients who were rand

287 Biopsy samples were taken from patients with COPD (Globa

288 Lesional skin biopsy samples were taken from this patient and 2 others

289 e, serological tests were used, and duodenal biopsy samples were taken to determine the degree of muc

290 Biopsy samples were tested for H. pylori using a reused

291 Encoded biopsy samples were then analysed by masked pathologists

292 ocal anaesthesia during collection of tumour biopsy sample) were expanded, seeded, and cultured with

293 e histological confirmation of surgical lung biopsy samples when high-resolution CT images are not de

294 o an assay applicable to routinely available biopsy samples, which enables exploration of its utility

295 ria DP macrophages, may be missed from pinch biopsy sampling, which may preclude detecting virus rese

296 n, a putative stem cell marker, in allograft biopsy samples with ACR compared to acute tubular injury

297 All renal allograft biopsy samples with concomitant data on 24-hour proteinu

298 In biopsy samples with high dendritic cell density, electro

299 omic hybridization analysis was performed on biopsy samples with sufficient tissue.

300 biopsies and find that implantation of whole biopsy samples without the addition of basement membrane